Clinical Trials Logo

Anoxic-Ischemic Encephalopathy clinical trials

View clinical trials related to Anoxic-Ischemic Encephalopathy.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03744481 Completed - Clinical trials for Anoxic-Ischemic Encephalopathy

Becoming Children With Perinatal Anoxo-Ischemic Encephalopathy Without Indication of Therapeutic Hypothermia

SARNATUN
Start date: May 19, 2019
Phase:
Study type: Observational

There are 3 levels of severity of anoxo-ischemic encephalopathy (EAI): mild, moderate and severe. Therapeutic hypothermia is beneficial in children with moderate EAI. It is ineffective in severe EAI and may be deleterious if there is no EAI. He continues to question his interest in light EAIs. There are few studies on the becoming of children with a mild anoxic-ischemic encephalopathy and not set hypothermia. The main hypothesis of the study is that term newborns with anoxo-ischemic encephalopathy who did not require therapeutic hypothermia have normal psychomotor development at 2 years.

NCT ID: NCT02231060 Completed - Clinical trials for Anoxic-Ischemic Encephalopathy

Study for the Improvement of Long-Term Outcome Prediction in Patients in Coma After Cardiac Arrest

HOPE
Start date: October 2014
Phase:
Study type: Observational [Patient Registry]

The primary objective of HOPE is to improve the accuracy of outcome prediction in anoxic-ischemic encephalopathy following cardiac arrest by bringing under close scrutiny some of the existing methods used for this purpose (e.g. somato-sensory evoked potentials). HOPE is the first multicenter prospective cohort study on coma prognosis to control for the effect of a possible self-fulfilling prophecy at the ICU and to cover the acute and neurorehabilitation phases with a long-term follow-up longer than the usual three or six months.